Aptose Biosciences Inc.·4

Dec 20, 4:33 PM ET

PLATZER ERICH 4

4 · Aptose Biosciences Inc. · Filed Dec 20, 2021

Insider Transaction Report

Form 4
Period: 2021-12-16
Transactions
  • Purchase

    Common Shares

    2021-12-16$1.40/sh+20,000$28,000505,000 total
  • Purchase

    Common Shares

    2021-12-16$1.38/sh+30,000$41,400485,000 total
  • Purchase

    Common Shares

    2021-12-16$1.37/sh+50,000$68,500455,000 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.365 to $1.39, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth above.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.395 to $1.40, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth above.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4